Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection

By rosaguerrero • July 29, 2022

Kelesidis T, Mantzoros CS. Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection. Metabolism. 2022 Jul 25;134:155267. doi: 10.1016/j.metabol.2022.155267. Epub ahead of print. PMID: 35901934; PMCID: PMC9313531.

Tags: Infectious Diseases, Publications

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

Parks KR, Moodie Z, Allen MA, Yen C, Furch BD, MacPhee KJ, Ozorowski G, Heptinstall J, Hahn WO, Zheng Z, Lu H, Grant S, Domin[...]

Mirtazapine reduces hypothetical methamphetamine demand in humans

Rush CR, Santos GM, McMahan VM, Fraser A, Clark J, Luna Marti X, Walker JE, Shoptaw S, Coffin PO. Mirtazapine reduces hypothetical methamphetamine demand in[...]

A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission

Ruis C, Lusamaki E, O'Toole A, Otieno JR, Colquhoun R, Roemer C, Wawina-Bokalanga T, Tshiani-Mbaya O, Jansen D, Makangara JC, Agrawal A, Abu-Raddad LJ, Ahuka-Mundeke[...]